STOCK TITAN
  1. Home
  2. Sec-filings
  3. MURA
  4. [Form 4] Mural Oncology plc Insider Trading Activity

[Form 4] Mural Oncology plc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MURA logo
Mural Oncology PLC

NASDAQ:MURA

MURA Rankings

#7192 Ranked by Market Cap
N/A Ranked by Dividends

MURA Latest News

May 19, 2025
Mural Oncology Announces Number of Relevant Securities in Issue
Apr 30, 2025
FORM 8.1(a) & (b) - Mural Oncology plc
Apr 15, 2025
Mural Oncology Announces Plans to Explore Strategic Alternatives
Mar 25, 2025
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian Cancer
Mar 11, 2025
Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones

MURA Latest SEC Filings

Jul 23, 2025
[Form 4] Mural Oncology plc Insider Trading Activity
Jul 22, 2025
[144] Mural Oncology plc SEC Filing
Jul 9, 2025
[144] Mural Oncology plc SEC Filing
Jul 9, 2025
[Form 4] Mural Oncology plc Insider Trading Activity
Jun 26, 2025
[SCHEDULE 13G] Mural Oncology plc SEC Filing

MURA Stock Data

43.00M
15.01M
1.62%
60.66%
2.09%
Biotechnology
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2